-
ALLR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Allarity Therapeutics (ALLR)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 1 |
Closed positions | 2 |
Increased positions | 2 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 33.82 mm |
Total shares | 5.83 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
3i | 2.99 mm | $0.00 |
Forsakringsaktiebolaget Avanza Pension | 1.37 mm | $259.00 k |
& Larsen ApS Sass | 1.06 mm | $0.00 |
Intracoastal Capital | 400.00 k | $262.00 k |
UBS UBS | 3.62 k | $23.87 mm |
Tower Research Capital | 1.43 k | $9.43 mm |
Acadian Asset Management | 32.00 | $0.00 |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep 24 | Jeremy R. Graff | Common Stock | Grant | Acquire A | No | No | 2.11 | 118,483 | 250.00 k | 118,483 |